Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
22/10/2026 22:52
BRIEF-Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development Oct 22 (Reuters) - Fortrea Holdings Inc FTRE.O:
FORTREA AND OMICO COLLABORATION TO ADVANCE BIOMARKER-LED ONCOLOGY DRUG DEVELOPMENT
Source text: ID:nGNX5ZH0FK
Further company coverage: FTRE.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Fortrea Holdings
See all newsFortrea Q3 revenue beats expectations on bookings momentum, guidance raised
Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Brief: Fortrea Completes Acquisition Of The Early Phase Services Division From Worldwide Clinical Trials
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike